Autolus Therapeutics announces publication in Blood Cancer Journal
March 11, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces publication in Blood Cancer Journal
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
February 29, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
Autolus Therapeutics announces publication in Nature Communications
February 22, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces publication in Nature Communications
Autolus Announces Pricing of Underwritten Offering
February 08, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Announces Pricing of Underwritten Offering
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
February 08, 2024 05:45 ET
|
Autolus Therapeutics plc; BioNTech SE
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
Autolus Therapeutics announces publication in ACS Chemical Biology
January 23, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces publication in ACS Chemical Biology
Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)
January 22, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces acceptance of BLA for obe-cel as a potential treatment for relapsed/refractory adult ALL
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
January 10, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
Autolus Therapeutics Announces Changes to its Board of Directors
December 22, 2023 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics Announces Changes to its Board of Directors
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
December 09, 2023 20:30 ET
|
Autolus Therapeutics plc
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023